Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

crotoxin

A toxic protein complex isolated from Crotalus durissus terrificus (South American rattlesnake) venom that is comprised of a basic neurotoxic subunit with phospholipase A2 (PLA2) activity and an acidic non-enzymatic, non-toxic subunit called crotapotin, with anticoagulant and immunomodulatory activities. The PLA2 subunit of crotoxin hydrolyzes the acyl groups in phosphoglycerides, acts as an anticoagulant by inhibiting the prothrombinase activity of coagulation factor Xa (F10a) and increases chloride-dependent current modulated by the cystic fibrosis transmembrane conductance regulator (CFTR). The PLA2 subunit may also metabolize eicosanoids, forming products that cause sequestration of lymphocytes in the lymph nodes and inhibit the spreading and phagocytic activity of macrophages. Crotoxin down-modulates the immune system, leading to the inhibition of both humoral and cellular immune responses.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Abbreviation:Ctrx
CTX
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search